Aon
VC Fund
London, United Kingdom
Aon is a global provider of risk management, insurance and reinsurance brokerage, human resources solutions, and outsourcing services. It employs over 60,000 people in 120 countries worldwide.ACIA is a unit of Aon, based in Dublin, which was set up in 2009. It is one of the first centers established in Ireland that are dedicated to data analyticsand innovation. ACIA provides analytical services that identify and create innovative new products and services for the many different divisions within Aon.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 60%
Last updated:
For AI agents: llms.txt
Industries Aon invests in
Stages Aon invests in
Countries Aon invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Lisa Stevens
|
|||
|
Farheen Dam
|
|||
Gregory Case
|
|||
James Trainor
|
|||
| See all 11 contacts → | |||
Investment Focus
Industry
- Software 6 (40%)
- Health Care 3 (20%)
- Manufacturing 3 (20%)
- Electronics 2 (13%)
- Biotechnology 2 (13%)
Stage
- Debt Financing 10 (67%)
- Series A 1 (7%)
- Series C 1 (7%)
- Corporate Round 1 (7%)
Country
- United States 11 (73%)
- South Korea 1 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Christa Davies
Executive Vice President and Chief Financial Officer
|
Executive Vice President and Chief Financial Officer | Total investments: 1 | Find email | |
|
Lisa Stevens
Chief Administrative Officer
|
Chief Administrative Officer | Total investments: 1 | Find email | |
|
Farheen Dam
Head of Health
|
Head of Health | Total investments: 1 | Find email | |
|
Gregory Case
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
|
James Trainor
Senior Vice President
|
Senior Vice President | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
eMed
|
eMed provides digital healthcare services that combine telehealth consultations, diagnostic testing, and treatment support through an integrated platform. The eMed Population Health app, funded by employers, is a personalized tool for weight management, helping users take control of their health. eMed facilitates easier connections with patientsthrough features like live video consultations and real-time scheduling. | $200M / Series A / Mar 26, 2026 | |
Position Imaging
|
Position Imaging offers package management and asset tracking technology that provides accurate real-time product, personnel, and equipment location awareness without the use of RFIDs, allowing organizations to improve key processes used in the manufacturing, shipping, and selling of goods. Position Imaging is leading the next phase of logisticsefficiency by leveraging user-friendly design, innovative software, and a global partner network. | $30M / Debt Financing / Oct 19, 2023 | |
Yield Engineering Systems
|
YES's cost-effective "lab-to-fab" range of vacuum curing, monolayer coating, and plasma cleaning systems is enabling innovation for companies across a wide spectrum of technology markets, including advanced packaging, IoT, life sciences, AR/VR, MEMS, power, automotive and sensors. | $55M / Debt Financing / Jun 14, 2023 | |
Embr Labs
|
Embr Labs is the first thermal wellness technology company that has harnessed the body’s natural response to temperature to enhance human wellbeing. Embr technology leverages temperature as a new pathway to the brain to balance the autonomic nervous system and helps individuals manage hot flashes, sleep disturbances, and anxiety. Embr Labs has tensof thousands of customers in 170 countries. Our customers have logged over 100M minutes and 6M sessions of thermal interventions. A mobile app and cloud infrastructure augment our wearable, forming a unique technology platform that combines thermal stimulation, digital interventions, and data to manage symptoms and treat disease. The technology was invented by the company’s founders while they were engineering students MIT. Embr Labs is backed by DigiTx Partners, Safar Partners, Joy Ventures, Bose Ventures, Intel Capital and others, and been awarded over $2.5M in grant funding from the NIH, DOD, and Massachusetts Life Sciences Center. | $35M / Debt Financing / May 03, 2023 | |
Leia
|
Leia Inc. is a leading provider of eyewear-free 3D display hardware and software solutions. Their breakthrough technology, born from pioneering research at HP Labs and Philips, leverages advanced optics and AI to transform ordinary displays into naturally immersive experiences. They envision a future where the three-dimensional reality of ourphysical world is seamlessly reflected in the digital space to transform the way we work, play, and connect — and strive to make 3D accessible to anyone, anywhere, on any device. | $125M / Debt Financing / Nov 03, 2022 | |
|
Leia
|
Leia Inc. is a leading provider of eyewear-free 3D display hardware and software solutions. Their breakthrough technology, born from pioneering research at HP Labs and Philips, leverages advanced optics and AI to transform ordinary displays into naturally immersive experiences. They envision a future where the three-dimensional reality of ourphysical world is seamlessly reflected in the digital space to transform the way we work, play, and connect — and strive to make 3D accessible to anyone, anywhere, on any device. | $125M / Debt Financing / Nov 03, 2022 | |
Anonos
|
Anonos is a global software company that provides the only technology capable of protecting data in use with 100% accuracy, even in untrusted environments, making otherwise restricted assets accessible to expand and expedite data-driven initiatives.Its patented Data Embassy platform transforms source data into Variant Twins: non-identifiable yet100% accurate data assets for specific use cases. Because multi-level data privacy and security controls are embedded into the data and technologically enforced, Variant Twins can travel anywhere – across departments, outside the enterprise, or around the globe. Therefore, projects for capturing valuable insights can advance without compromising privacy, security, accuracy, or speed. | $50M / Debt Financing / Oct 19, 2022 | |
Rznomics
|
Rznomics Inc. is a South Korean biotechnology company developing RNA-based gene therapies for cancer, genetic, and neurodegenerative diseases. The company focuses on trans-splicing ribozyme and circular RNA technologies, with pipeline candidates targeting liver cancer, glioblastoma, Alzheimer’s disease, and retinal disorders. | $29.6M / Series C / Jun 08, 2022 | |
GRUBBRR
|
GRUBBRR is an emerging technology company that delivers ordering solutions for small to large companies across different verticals including QSR Restaurants, Fast-Casual Restaurants, Cafes, Bars, Food Trucks, Coffee Shops, Bakeries, Stadiums, Movie Theatres, and Golf Courses. Offerings include self-service kiosks, point-of-sale systems, mobileordering, online ordering, tableside ordering, food lockers and other services intended to materially increase business efficiency. | $35M / Debt Financing / Jun 01, 2022 | |
iM3NY
|
iM3NY is a startup lithium ion battery cell manufacturing company with HQ and Gigafactory located in Endicott, NY. We are developing a cell manufacturing Gigafactory on Huron Campus, the birthplace of IBM.We have a proprietary BMLMP cell chemistry that offers significant advancement over other phosphate based cell chemistries (for example LFP).The company has raised significant funding over 2020-22 and is fully funded for the completion of our first 1 gigawatt-hours per year (GWh/yr) Gigafactory, that will begin production during summer 2022. Future plans are to expand production capabilities to 32+ GWh over the next 8 years. | $100M / Debt Financing / Apr 19, 2022 | |
| See all 15 investments → | |||
Co-Investors
Ghost Tree Partners
4 deals together
IBK Capital
1 deal together
Korea Development Bank
1 deal together
Korea Development Bank
1 deal together
Partners Investment
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Aon invest in?
Aon invests primarily in Software, Health Care and Manufacturing startups, most often at Debt Financing and Series A stage. Most of the 15 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Aon?
Public channels for Aon include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aon?
The team at Aon includes Christa Davies (Executive Vice President and Chief Financial Officer), Lisa Stevens (Chief Administrative Officer) and Farheen Dam (Head of Health), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
